Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

N/AActive Not RecruitingNCT06608251

Nanjing First Hospital, Nanjing Medical University100 enrolled

Overview

The cases were screened according to the inclusion criteria, and after the patients signed the informed consent, the clinical data were collected, the imaging data were evaluated, and blood samples were taken for follow-up measurements. In the early morning of the second day after the patient was enrolled, 5mL of peripheral venous blood was drawn and sent to the neurology laboratory of our hospital for separation, and the detection of plasma metabolomics markers was performed.

In the early morning of the second day after the patient was enrolled, 5mL of peripheral venous blood was drawn and sent to the neurology laboratory of our hospital for separation, and the detection of plasma metabolomics markers was performed.Inluding CRP，Complete blood count，Liver and kidney function indicators，et.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Myelinopathy

Interventions

white matter lesionDIAGNOSTIC_TEST

According to the results of magnetic resonance, they were divided into white matter degeneration group and non-white matter degeneration group

Eligibility

Sex: ALLMin age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria： 1. Be older than 45 years old; 2. Patients admitted to the Department of Neurology due to headache, vertigo, anxiety, etc.; 3. There were no symptoms of neurological deficit on physical examination; 4. Able to cooperate with the improvement of brain MRI examination; 5. Sign the informed consent form. Exclusion Criteria: 1. History of stroke, traumatic brain injury, intracranial tumor, central nervous system infection, active malignant tumor, thyroid disease, autoimmune disease, active or chronic inflammatory disease, severe liver and kidney impairment, etc.; 2. accompanied by neurological deficit symptoms; 3. refusal to participate in the study; 4. Other conditions judged by the investigator to be unsuitable for enrollment.

Locations (1)

Nanjing First Hospital

Nanjing, Jiangsu, China

Outcomes

Primary Outcomes

myelinopathy

The degree of damage to the white matter of the brain is judged based on the magnetic resonance Fazekas score(1-3), with the higher scores indicating the damage more severe.

Time frame: 2024.06.01-2027.06.01

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.